Axon today urged an appeals court to permit federal court review now of its constitutional claims against the US Federal Trade Commission, saying they are separate from the merits of an ongoing dispute over the Axon-VieVu deal.Two members of the three-judge panel on the US Court of Appeals for the Ninth Circuit